Jaguar's commercial focus on cancer supportive care aims to use the best tools and techniques that assess the quality of life of cancer patients and survivors and deliver solutions to address these unmet needs - Commonly used tools and techniques fail to measure what patients are most concerned about
Jaguar family company Napo Pharmaceuticals sponsored the "More Than a Diagnosis: A Quality of Life Survey for Individuals with a Diagnosis or History of Cancer"
Read More
- 2024 Second Quarter Sales Surpass Total 2023 Sales; Company Reports Sequential Quarterly Revenue Growth of 114% -
- Company Accelerates Real-World Adoption of its AI-Powered Drone Imagery Analysis Platform in Ukraine -
Read More